MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$474,800K
Inventories
$3,200,800K
Accounts receivable, net
$5,741,100K
Marketable securities
$5,487,100K
Cash and cash
equivalents
$3,118,100K
Other noncurrent
assets
$1,821,200K
Deferred tax assets
$4,077,200K
Intangible assets, net
$1,257,400K
Property, plant, and
equipment, net
$5,120,400K
Marketable securities
$10,260,600K
Total current assets
$18,021,900K
Total assets
$40,558,700K
Total liabilities and
stockholders' equity
$40,558,700K
Total stockholders'
equity
$31,256,900K
Total liabilities
$9,301,800K
Treasury stock, at cost
33.7 shares in 2025...
$18,612,800K
Accumulated other
comprehensive income (loss)
$77,500K
Retained earnings
$35,797,100K
Other noncurrent
liabilities
$2,018,800K
Deferred revenue
$208,700K
Finance lease
liabilities
$720,000K
Long-term debt
$1,985,900K
Total current
liabilities
$4,368,400K
Additional paid-in capital
$13,995,000K
Common stock-Common
Stock
$100K
Deferred revenue
$553,000K
Accrued expenses and
other current...
$2,876,400K
Accounts payable
$939,000K
Back
Back
Balance Sheet
source: myfinsight.com
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)